Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Total Liabilities : ¥1,871 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Jiangsu Kanion Pharmaceutical Co Total Liabilities?

Jiangsu Kanion Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,871 Mil.

Jiangsu Kanion Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2023 (¥1,509.15 Mil) to Dec. 2023 (¥1,736.77 Mil) and increased from Dec. 2023 (¥1,736.77 Mil) to Mar. 2024 (¥1,870.61 Mil).

Jiangsu Kanion Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (¥1,545.30 Mil) to Dec. 2022 (¥1,861.81 Mil) but then declined from Dec. 2022 (¥1,861.81 Mil) to Dec. 2023 (¥1,736.77 Mil).

Jiangsu Kanion Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Jiangsu Kanion Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Kanion Pharmaceutical Co Total Liabilities Chart

Jiangsu Kanion Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

2,023.39

1,791.78

1,545.30

1,861.81

1,736.77

Jiangsu Kanion Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,641.30	1,694.50	1,509.15	1,736.77	1,870.61

Jiangsu Kanion Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jiangsu Kanion Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1608.688	+	(0	+	128.081
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,737

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	7117.322	-	5380.553
	=	1,737

Jiangsu Kanion Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1714.117	+	(0	+	156.496
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,871

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	7379.971	-	5509.358
	=	1,871

Jiangsu Kanion Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Jiangsu Kanion Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 58 Haichang South Road, Xinpu District, Jiangsu, Lianyungang, CHN, 222001

Website

http://www.kanion.com

Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.

Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Headlines

No Headlines